MRNA-seq-based Analysis Predicts: AEG-1 is a Therapeutic Target and Immunotherapy Biomarker for Pan-cancer, Including OSCC

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2024 Nov 1

PMID 39483471

Authors

Lihong Yao

Lixue Liu

Wanqiu Xu

Hualei Xi

Song Lin

Guiyan Piao

Ying Liu

Jinrong Guo

Xiumei Wang

Affiliations

Soon will be listed here.

Abstract

Background: The aberrant expression of AEG-1 is significantly correlated with tumorigenesis, development, neurodegeneration and inflammation. However, the relationship between AEG-1 expression and immune infiltration in OSCC, as well as other tumor types, has yet to be comprehensively analyzed.

Methods: The expression levels, prognostic and clinicopathological characteristics, mutation patterns and methylation landscapes of AEG-1 in various tumors were obtained from multiple databases, including TIMER, GEPIA, HPA, TCGA, UALCAN, cBioPortal, SMART and TISIDB, in addition to single-cell RNA-seq data. The integration of these datasets facilitated the elucidation of the relationships among pan-cancer cellular heterogeneity, immune infiltration and AEG-1 expression levels. experiments created AEG-1 overexpressing cell lines, and mRNA-seq analyzed AEG-1-related differential genes in OSCC. RT-PCR validated these findings using xenograft tumors. Tumor cell lines were developed to study AEG-1's effects through H&E, Masson, and PAS staining. Immunohistochemistry examined AEG-1-related gene expression patterns.

Results: Our analysis demonstrated that AEG-1 is highly expressed across various cancer types and is associated with tumor grade and patient prognosis. Additionally, AEG-1 amplification was observed in multiple cancers. Notably, we identified a significant elevation of AEG-1 expression in OSCC, which strongly correlated with patient prognosis and immune infiltration. Through mRNA-seq analysis of differentially expressed genes and immune-related gene sets, we identified a strong correlation between AEG-1 and immune infiltration markers such as LCP2, CD247, HLA-DPA1, HLA-DRA, HLA-DRB1, CIITA and CD74 in OSCC. Additionally, AEG-1 was found to regulate Th1/Th2 immune homeostasis, promote glycogen accumulation, and contribute to tumor fibrosis.

Conclusion: In conclusion, AEG-1 significantly correlates with prognosis and immune infiltration across various cancer types and holds potential as a novel prognostic immune biomarker for OSCC. This finding may facilitate the identification of patients who are most likely to benefit from adjuvant immunotherapy.

References

Sutherland H, Lam Y, Briers S, Lamond A, Bickmore W . 3D3/lyric: a novel transmembrane protein of the endoplasmic reticulum and nuclear envelope, which is also present in the nucleolus. Exp Cell Res. 2004; 294(1):94-105. DOI: 10.1016/j.yexcr.2003.11.020. View

Gijtenbeek R, de Jong K, Venmans B, van Vollenhoven F, Ten Brinke A, van der Wekken A . Best first-line therapy for people with advanced non-small cell lung cancer, performance status 2 without a targetable mutation or with an unknown mutation status. Cochrane Database Syst Rev. 2023; 7:CD013382. PMC: 10327404. DOI: 10.1002/14651858.CD013382.pub2. View

Hu X, Zhu H, Chen B, He X, Shen Y, Zhang X . Tubulin Alpha 1b Is Associated with the Immune Cell Infiltration and the Response of HCC Patients to Immunotherapy. Diagnostics (Basel). 2022; 12(4). PMC: 9031616. DOI: 10.3390/diagnostics12040858. View

Liu Y, Wei G, Ma Q, Han Y . Knockdown of long noncoding RNA TP73-AS1 suppresses the malignant progression of breast cancer cells in vitro through targeting miRNA-125a-3p/metadherin axis. Thorac Cancer. 2020; 11(2):394-407. PMC: 6996984. DOI: 10.1111/1759-7714.13283. View

Yan J, Zhang J, Zhang X, Li X, Li L, Li Z . AEG-1 is involved in hypoxia-induced autophagy and decreases chemosensitivity in T-cell lymphoma. Mol Med. 2018; 24(1):35. PMC: 6038315. DOI: 10.1186/s10020-018-0033-6. View

Guo X, Chen S, Wang S, Zhang H, Yin F, Guo P . CircRNA-Based Cervical Cancer Prognosis Model, Immunological Validation and Drug Prediction. Curr Oncol. 2022; 29(11):7994-8018. PMC: 9689098. DOI: 10.3390/curroncol29110633. View

Sriramulu S, Sun X, Malayaperumal S, Ganesan H, Zhang H, Ramachandran M . Emerging Role and Clinicopathological Significance of AEG-1 in Different Cancer Types: A Concise Review. Cells. 2021; 10(6). PMC: 8232086. DOI: 10.3390/cells10061497. View

Britt D, Yang D, Yang D, Flanagan D, Callanan H, Lim Y . Identification of a novel protein, LYRIC, localized to tight junctions of polarized epithelial cells. Exp Cell Res. 2004; 300(1):134-48. DOI: 10.1016/j.yexcr.2004.06.026. View

Jeong S, Choi Y, Kim K . Engineering Therapeutic Strategies in Cancer Immunotherapy via Exogenous Delivery of Toll-like Receptor Agonists. Pharmaceutics. 2021; 13(9). PMC: 8466827. DOI: 10.3390/pharmaceutics13091374. View

10.

Chen W, Dai X, Chen Y, Tian F, Zhang Y, Zhang Q . Significance of STAT3 in Immune Infiltration and Drug Response in Cancer. Biomolecules. 2020; 10(6). PMC: 7355836. DOI: 10.3390/biom10060834. View

11.

Liu J, Wang Y, Yin J, Yang Y, Geng R, Zhong Z . Pan-Cancer Analysis Revealed as a New Biomarker for Prognosis and Immunotherapy. J Oncol. 2022; 2022:3477148. PMC: 8769850. DOI: 10.1155/2022/3477148. View

12.

Shen Z, Zhang J, Chen H, Wang W, Xu W, Lu X . Does Pre-operative Biliary Drainage Influence Long-Term Survival in Patients With Obstructive Jaundice With Resectable Pancreatic Head Cancer?. Front Oncol. 2020; 10:575316. PMC: 7525216. DOI: 10.3389/fonc.2020.575316. View

13.

Luo L, Zhang Z, Weng Y, Zeng J . Ferroptosis-Related Gene GCLC Is a Novel Prognostic Molecular and Correlates with Immune Infiltrates in Lung Adenocarcinoma. Cells. 2022; 11(21). PMC: 9657570. DOI: 10.3390/cells11213371. View

14.

Talvitie E, Vilhonen H, Kurki S, Karlsson A, Orte K, Almangush A . High tumor mutation burden predicts favorable outcome among patients with aggressive histological subtypes of lung adenocarcinoma: A population-based single-institution study. Neoplasia. 2020; 22(9):333-342. PMC: 7317687. DOI: 10.1016/j.neo.2020.05.004. View

15.

Brown D, Ruoslahti E . Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. Cancer Cell. 2004; 5(4):365-74. DOI: 10.1016/s1535-6108(04)00079-0. View

16.

He L, Peng X, Cao H, Yang K, Xiang L, Li R . The Gene Family in : Genome-Wide Investigation and Expression Analysis in Response to Cadmium Stress. Genes (Basel). 2023; 14(1). PMC: 9859093. DOI: 10.3390/genes14010183. View

17.

Song Y, Ma R . Identifying the Potential Roles of PBX4 in Human Cancers Based on Integrative Analysis. Biomolecules. 2022; 12(6). PMC: 9221482. DOI: 10.3390/biom12060822. View

18.

Yuan J, Wang Y, Cao Y, Yue S, Li X . Application of Nanoparticles in Diagnosis and Treatment of Pancreatic Cancer. Bioinorg Chem Appl. 2022; 2022:7803001. PMC: 9192299. DOI: 10.1155/2022/7803001. View

19.

Veigas F, Mahmoud Y, Merlo J, Rinflerch A, Rabinovich G, Girotti M . Immune Checkpoints Pathways in Head and Neck Squamous Cell Carcinoma. Cancers (Basel). 2021; 13(5). PMC: 7957692. DOI: 10.3390/cancers13051018. View

20.

Lee S, Choi K, Bang G, Park S, Kim E, Choi J . Identification of Nucleolin as a Novel AEG-1-Interacting Protein in Breast Cancer via Interactome Profiling. Cancers (Basel). 2021; 13(11). PMC: 8201222. DOI: 10.3390/cancers13112842. View